-
Forward Look
Making Cancer Clinical Trials More InclusiveDespite efforts by policymakers, a gender gap persists in clinical trial participation.
by Lindsey Konkel
-
Forward Look
New Therapies for Metastatic Lung CancerSeveral targeted drugs were approved in 2020 to treat the most common type of lung cancer.
by Ashley P. Taylor
-
Forward Look
Immunotherapy Shows Promise for Treating Brain MetastasesTreatments capable of crossing the blood-brain barrier provide new options for patients whose cancer has spread to the brain.
by Bradley Jones
-
Forward Look
A Strategy to WatchSome rectal cancer patients may safely avoid life-altering surgery.
by Kristine Conner
-
Forward Look
Older Adults at Risk for Cancer OverscreeningMany older adults continue to be screened beyond the recommended age.
by Carisa Brewster
-
Healthy Habits
Daily DoseAspirin can be taken daily to reduce the risk of colorectal cancer, but it's not recommended for everyone.
by Bradley Jones
-
Forward Look
What’s Next? Spring 2021A new way to evaluate patients with prostate cancer.
by Christina Bennett
-
More Ways to Treat Advanced Kidney CancerNew drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.
by Kendall K. Morgan
-
When Cancer’s Spread Is LimitedPeople with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
-
Facts and Stats
The Five Phases of Clinical ResearchNew treatments in the U.S. are scrutinized in various ways before and after they are approved by the Food and Drug Administration.
by Bradley Jones
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
